中文 | English
Return
Total: 61 , 1/7
Show Home Prev Next End page: GO
MeSH:(Drug and Narcotic Control)

1.The ethical problem in pharmaceutical practice

Luan Van Dinh

Pharmaceutical Journal 2000;269(12):2-3

3.Comparison of Approval Process for Nonprescription Drugs in Different Countries.

Joo Hee KIM ; Jeong YEE ; Gwan Yung LEE ; Kyung Eun LEE ; Hye Sun GWAK

Korean Journal of Clinical Pharmacy 2018;28(4):263-272

4.Suggestion on standardizing clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia 2010 edition.

Xuemin GAO ; Boli ZHANG ; Gansheng ZHONG ; Deqin ZHANG

China Journal of Chinese Materia Medica 2009;34(22):2972-2974

6.Regulations of residual solvents in pharmaceuticals and advances in the research of its analytical methods.

Chang-qin HU ; Ying LIU

Acta Pharmaceutica Sinica 2007;42(12):1237-1242

7.Rationality analysis on current validity period of preparations in medical institutions.

Yaping LIN

China Journal of Chinese Materia Medica 2010;35(15):2038-2040

8.Regulations and guidelines should be strengthened urgently for re-evaluation on post-marketing medicines in China.

Yan-Ming XIE ; Feng TIAN

Chinese journal of integrative medicine 2013;19(7):483-487

9.Correlation of bacteria in the contaminated drug and the environmental microbes in the clean room for pharmaceutical microbial test investigated by FTIR.

Lin PEI ; Chang-qin HU ; Shi-hong MA ; Hui DAI ; Tai-jun HANG

Acta Pharmaceutica Sinica 2007;42(11):1189-1194

10.Status and thinking of supervision and management of Chinese herbal medicine.

Xiao-Yu XIE

China Journal of Chinese Materia Medica 2013;38(11):1832-1835

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 61 , 1/7 Show Home Prev Next End page: GO